References
- Åkerlund M, Strömberg P, Forsling ML.Primary dysmenorrhea and vasopressinBr J Obstet Gynaecol1979; 86484–7
- Strömberg P, Åkerlund M, Forsling ML, Granström E, Kindahl H.Vasopressin and prostaglandins in premenstrual pain and in primary dysmenorrheaActa Obstet Gynecol Scand1984; 63533–8
- Ekström P, Åkerlund M, Forsling M, Kindahl H, Laudanski T, Mrugacz G.Stimulation of vasopressin release in women with primary dysmenorrhea and after oral contraceptive treatment-effect of uterine contractilityBr J Obstet Gynaecol1992; 99680–4
- Jard S, Elands J, Schmidt A, Barberis C. Vasopressin and oxytocin receptors: an overview. , In: Progress in Endocrinology. Imura H and Shizurne K Exerpta Medica, Amsterdam, 1988; 1183–8.
- Thibonnier M, Auzan C, Madhun Z, Wilkins P, Berti-Mattera L, Clauser E.Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptorJ Biol Chem1994; 2693304–10
- Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H.Molecular cloning and functional expression of a cDNA oncoding the human V1b vasopressin receptorJ Biol Chem1994; 26927088–92
- Bossmar T, Åkerlund M, Fantoni G, Szamatowicz J, Melin P, Maggi M.Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist AtosibanAm J Obstet Gynecol1994; 1711634–42
- Bossmar T, Åkerlund M, Szamatowicz J, Laudanski T, Fantoni G, Maggi M.Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant womenBr J Obstet Gynaecol1995; 102907–12
- Ekström P, Alm P, Åkerlund M.Differences in vasomotor responses between main stem and smaller branches of the human uterine arteryActa Obstet Gynecol Scand1991; 70429–33
- Kostrzewska A, Laudanski T, Batra S.Effect of ovarian steroids and diethylstilbestrol on the contractile responses of the human myometrium and intramyometrial arteriesEur J Pharmacol1993; 233127–34
- Kostrzewska A, Laudanski T, Batra S. Potent inhibition of tamoxifen of spontaneous and agonist-induced contractions of the human myometrium and intramyometrial arteries. Am J Obstet Gynecol 1997; 176: (, in press).
- Bossmar T, Rasmussen T, Åkerlund M.Effect of the nonpeptide, vasopressin Vla receptor antagonist, SR 49059, and its enantiomer, SR 49770, on isolated human myometriumActa Obstet Gynecol Scand1996; 75516–19
- Bossmar T, Brouard R, Döberl A, Åkerlund M.Effects of SR 49059, an orally active Vla vasopressin receptor antagonist on vasopressin-induced uterine contractions in womenBr J Obstet Gynaecol1997; 104471–7
- Waud DR. Analysis of dose-response curves. , In: Methods in Pharmacology, Daniel EE, Paton DM New York and London, Plenum Press 1975; vol. 3, ch. 27.
- Arunlakshana O, Schildt HO.Some quantitative uses of drug antagonistsBr J Pharmacol1959; 1448–58
- Somlyo AP, Somlyo AV.Signal transduction and regulation in smooth muscleNature1994; 372231–6
- Serradeil-Le-Gal C, Wagnon J, Garcia C, Lacour C, Gui-raudou P, Christophe B, et alBiochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptorJ Clin Invest1994; 92224–31
- Serradeil-Le-Gal C, Herbert JM, Delisée C, Schaeffer P, Raufaste D, Garcia C , et al. Effect of SR 49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells. Am J Physiol (Heart Circ. Physiol 37) 1995; 268: H404–410.